HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that Tom Farrell, President and CEO, is scheduled to present at the Jefferies 2016 Global Healthcare Conference. The presentation will take place on Wednesday, June 8 at 3:30 p.m. EDT in New York City.
